Skip to main content

MoneyWorks4Me

Lupin submits board meeting intimation

25 Apr 2023 Evaluate
Lupin has informed that the meeting of the Board of Directors of the Company is scheduled on 09/05/2023, to consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2023 and recommend dividend, if any.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..